Publication | Open Access
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial
482
Citations
25
References
2017
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1